Results 101 to 110 of about 961,624 (248)

Umbilical cord blood natural killer cells for adoptive immunotherapy: identifying optimal starting material and processing parameters

open access: yesFrontiers in Immunology
IntroductionUmbilical cord blood (UCB) is an attractive source of natural killer (NK) cells for the development of allogeneic ‘off-the-shelf’ cancer immunotherapies.
M. G. Kennedy   +14 more
doaj   +1 more source

Data, not documents: Moving beyond theories of information‐seeking behavior to advance data discovery

open access: yesJournal of the Association for Information Science and Technology, Volume 76, Issue 4, Page 649-664, April 2025.
Abstract Many theories of human information behavior (HIB) assume that information objects are in text document format. This paper argues four important HIB theories are insufficient for describing users' search strategies for data because of assumptions about the attributes of objects that users seek.
Anthony J. Million   +3 more
wiley   +1 more source

Relationship between continuous infusion meropenem PK/PD target attainment and C‐reactive protein dynamics in onco‐haematologic patients with febrile neutropenia

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aim Meropenem is a second‐line antimicrobial agent in the treatment of febrile neutropenia in onco‐haematological patients. A population pharmacokinetic/pharmacodynamic (PK/PD) analysis for assessing the relationship between meropenem exposure and C‐reactive protein (C‐RP) over time was conducted.
Chun Liu   +7 more
wiley   +1 more source

Model‐informed optimal dose selection of golcadomide in combination with R‐CHOP in patients with previously untreated aggressive B‐cell lymphoma

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Golcadomide is a potential first‐in‐class oral CELMoD™ agent for the treatment of lymphoma. This study aims to develop model‐informed drug development (MIDD) approaches to support optimal dose selection of golcadomide in combination with immunotherapy rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (R‐CHOP) in alignment with ...
Xirong Zheng   +7 more
wiley   +1 more source

Aircraft Level Thermal Management Analysis for Early Design Stages of Future Aircraft: Integration of Systems and Compartments into an Interacting Generic Approach

open access: yesEngineering Proceedings
For future commercial aircraft having hybrid electric drivetrains, the impact of electrical power generation and distribution on heat production and required heat rejection is of a larger magnitude than for conventional aircraft.
Jaap van Muijden, Jos Aalbers
doaj   +1 more source

The theatre of Anthony Neilson

open access: yes, 2018
Anthony Neilson is one of the most exciting and challenging voices in contemporary British theatre. This volume provides the first full-length study of his plays and his innovative rehearsal methodology.
Reid, Trish
core   +2 more sources

Paediatric clonidine medication errors: Findings from a multicentre French study

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims This study aimed to describe the characteristics of medication errors involving clonidine in paediatric patients and reported to French Network of Pharmacovigilance and Poison Control Centres. Methods This retrospective observational study analysed clonidine‐related medication errors reported between 1985 and June 2024 in patients under 12 years ...
Eve‐Marie Thillard   +8 more
wiley   +1 more source

A Registry‐Led Initiative Supporting United Kingdom Transplant Centers in Selection, Requesting, and Handling of Cord Blood Units for Hematopoietic Stem Cell Transplantation

open access: yesStem Cells Translational Medicine, 2019
Roger Horton   +9 more
doaj   +1 more source

Re‐evaluating variability of circulating miR‐122 in healthy volunteers: Implications for biomarker qualification in drug‐induced liver injury

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Drug‐induced liver injury (DILI) remains a major challenge in clinical practice and drug development, and reliable biomarkers are still needed. MicroRNA‐122 (miR‐122) has shown promise, but reported inter‐individual variability in healthy populations has raised concerns about its clinical utility.
Irum Javid   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy